Ref.: 1
Store in a closed container, at room temperature, protected from light.
Newer GLP-1 options Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, is in late-stage clinical trials and showing even greater weight loss potential than current options
Deep hydration for delicate, thin eye skin
100 mg/mL Usual Adult Dose for: Usual Pediatric Dose for: Additional dosage information: Usual Adult Dose for Carnitine Deficiency METABOLIC DISORDERS: Primary or secondary carnitine deficiency: Oral solution: Initial dose: 1 gram orally daily in evenly spaced divided doses (every 3 to 4 hours) Maintenance dose: 1 to 3 grams orally daily in evenly spaced divided doses (every 3 to 4 hours) Oral tablets: 990 mg orally 1 to 3 times a day, depending on clinical response Intravenous solution: 50 mg/kg as a slow 2 to 3 minute bolus or by infusion, once a day A loading dose may be given in severe metabolic crisis, followed by an equivalent dose every 3 to 4 hours (but not less often than every 6 hours) over the following 24 hours Subsequent daily doses should be in the range of 50 mg/kg or as therapy may require The highest dose administered has been 300 mg/kg
Known as The Glow Peptide, GHK-Cu is unique because it works at the DNA level to promote collagen production and reduce inflammation